Designing Effective Rare Disease Drug Formulations
Designing Effective Formulations for Rare Disease Drugs
The development of therapies for rare diseases presents unique formulation challenges where small patient populations, diverse disease presentations,...
Sustainable Formulation and Green Chemistry in Pharma
The Future of Sustainable Formulation and Green Chemistry
The pharmaceutical industry stands at a pivotal moment where environmental responsibility converges with therapeutic innovation. Sustainable formulation...
Building Regulatory Readiness in Biologics Formulation
The development of biologic therapies demands meticulous navigation through complex regulatory landscapes where scientific innovation must align with evolving compliance frameworks. Regulatory readiness biologics...
Smart Materials for Controlled Release Systems
Smart Materials Driving the Future of Controlled Release
The pharmaceutical landscape witnesses transformative advances as smart materials controlled release systems redefine therapeutic delivery paradigms. These...
Formulation Challenges in Biosimilars Development
Overcoming Formulation Barriers in Biosimilars Development
The biosimilar landscape represents one of the most dynamic and challenging frontiers in pharmaceutical development, where scientific complexity intersects...
Enhancing Stability in Biologics Formulation
Enhancing Stability and Shelf Life in Biologics Formulation
Biologic therapies have revolutionized treatment across diverse disease areas, yet their complex structures and sensitivity to environmental...
FDA Approves Celltrion’s EYDENZELT for Retinal Diseases
Celltrion, Inc. said the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), a biosimilar of EYLEA® (aflibercept), for several retinal conditions. These...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...